Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
about
Comparative efficacy, tolerability, and survival outcomes of various radiopharmaceuticals in castration-resistant prostate cancer with bone metastasis: a meta-analysis of randomized controlled trialsMinimally invasive local treatments for bone and pulmonary metastasesDiagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation OncologyRadiofrequency ablation of osseous metastases for the palliation of pain.Prospective dosimetry with 99mTc-MDP in metabolic radiotherapy of bone metastases with 153Sm-EDTMP.Clinical benefits of alpharadin in castrate-chemotherapy-resistant prostate cancer: case report and literature reviewClinical management of pain in advanced lung cancer.Auger radiation targeted into DNA: a therapy perspective.The rationale for a multimodal approach in the management of breakthrough cancer pain: a review.Treatment efficacy of (153)Sm-EDTMP for painful bone metastasis.Samarium-153-ethylene diamine tetramethylene phosphonate, a beta-emitting bone-targeted radiopharmaceutical, useful for patients with osteoblastic bone metastasesRadiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancerOptimal management of bone metastases in breast cancer patients.Cancer pain: part 1: Pathophysiology; oncological, pharmacological, and psychological treatments: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners.Bone metastasis in prostate cancer: emerging therapeutic strategies.Treatment of metastatic breast cancer in women aged 65 years and older.Sequencing systemic therapies in metastatic castration-resistant prostate cancer.A multi-targeted approach to treating bone metastases.Managing bone metastases and reducing skeletal related events in prostate cancer.Radiopharmaceuticals for metastatic bone pain palliation: available options in the clinical domain and their comparisons.Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods.Strontium-89 therapy for the treatment of huge osseous metastases in prostate carcinoma: A case reportRole of Radionuclide Therapy as Adjuvant to Palliative External Beam Radiotherapy for Painful Multiple Skeletal Metastasis.The Japanese Breast Cancer Society clinical practice guideline for radiotherapy of breast cancer.EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides.Improving the dose-myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMP.Influence of human biokinetics of strontium on internal ingestion dose of 90Sr and absorbed dose of 89Sr to organs and metastases.
P2860
Q26785658-FC1D494B-2D3E-4B58-8ED1-9578A10FB30EQ26849767-3F980985-87C3-47B8-AB90-6C3E8B4F896DQ28076646-4D87D271-C5CD-4988-951D-21EC4578B579Q34008354-1A90E899-FA2A-46F6-BC46-148988098D0BQ34596236-50BD5920-C5CF-4FD5-B800-82FB184522CDQ35980781-B7300FC3-0DD4-4E77-A702-9111C0C03625Q36327481-5C377D0D-825E-455D-8228-C86FD21D88D8Q36560317-262F6C41-EB3F-4A07-93EF-A9AC6D14FD47Q36854479-5A609670-EAC8-4443-AF7C-EA421CECE678Q37077241-B7B26C54-89AD-4397-9B54-4647501F6319Q37103630-98624C47-20A4-45E9-BA93-1D058C3920DFQ37168396-0705FDFA-CB8C-420F-9F77-2B6AFD19C3DBQ37355487-B1FD652D-D99F-4CE0-AC15-A00FFC89CEA7Q37764968-66D0DE5B-C844-4CBC-B27B-0A8F1BBF0A8FQ37873719-2466B344-14D8-45E4-B202-49BC969CCD89Q38023511-B3871D73-5F77-40A6-9215-46E17BFD2789Q38118056-A38843B1-EB64-4C4B-8336-67B04B2E1FACQ38175846-B57396C2-1281-457E-B2A5-6D03309EA398Q38211359-8DF6AB48-23D2-4E08-A784-0CF72804F4ADQ39042390-FAC2CA39-93AA-4822-A09D-02EEEE0FBFA4Q39103173-9D00C974-5CE9-4DE4-8172-4D3F61B33197Q39232513-A3382BFC-8343-4FB9-BADA-62AB78EBCEEEQ47142819-DD0980AE-F403-42D7-9D12-BD4C2E87FFFCQ48661178-2DC412BF-B508-4707-9900-3E9360580D74Q49908522-A5DED82A-6891-4377-84EF-0FBF2E8ABC9FQ50485352-38899379-6E3F-424C-84FC-8F4566EEC70CQ50662218-CE97A3F5-1CAF-40C0-A26B-59E34EB758E4
P2860
Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
@ast
Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
@en
type
label
Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
@ast
Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
@en
prefLabel
Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
@ast
Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.
@en
P2093
P1476
Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review
@en
P2093
Jinka Sathya
Manya Charette
Robert Reid
P304
P356
10.1016/J.RADONC.2005.03.003
P50
P577
2005-06-01T00:00:00Z